American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Adobe (NASDAQ:ADBE) Receives Buy Rating from Mizuho

Adobe (NASDAQ:ADBE) Receives Buy Rating from Mizuho

Mizuho reiterated their buy rating on shares of Adobe (NASDAQ:ADBE – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. They currently have a $680.00 price target on the software company’s... More of this article »
Image about Check Point Software Technologies (NASDAQ:CHKP) Receives “Neutral” Rating from Mizuho

Check Point Software Technologies (NASDAQ:CHKP) Receives “Neutral” Rating from Mizuho

Mizuho reiterated their neutral rating on shares of Check Point Software Technologies (NASDAQ:CHKP – Free Report) in a report published on Wednesday morning, Benzinga reports. They currently have a $160.00 price objective on... More of this article »
Image about Prospector Capital (NASDAQ:PRSRU) Stock Price Down 0.7%

Prospector Capital (NASDAQ:PRSRU) Stock Price Down 0.7%

Prospector Capital Corp. (NASDAQ:PRSRU – Get Free Report)’s stock price dropped 0.7% during mid-day trading on Wednesday . The company traded as low as $3.60 and last traded at $4.43. Approximately 6,300 shares changed... More of this article »
Image about Catalyst Pharmaceuticals (NASDAQ:CPRX) Given “Outperform” Rating at Oppenheimer

Catalyst Pharmaceuticals (NASDAQ:CPRX) Given “Outperform” Rating at Oppenheimer

Oppenheimer reiterated their outperform rating on shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $29.00 price target... More of this article »
Image about Krispy Kreme (NASDAQ:DNUT) Given New $19.00 Price Target at Citigroup

Krispy Kreme (NASDAQ:DNUT) Given New $19.00 Price Target at Citigroup

Krispy Kreme (NASDAQ:DNUT – Free Report) had its target price raised by Citigroup from $14.00 to $19.00 in a report released on Wednesday, Benzinga reports. They currently have a neutral rating on the stock. Other research analysts... More of this article »
Image about GlycoMimetics’ (GLYC) “Buy” Rating Reaffirmed at HC Wainwright

GlycoMimetics’ (GLYC) “Buy” Rating Reaffirmed at HC Wainwright

HC Wainwright reiterated their buy rating on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a report issued on Wednesday, Benzinga reports. The firm currently has a $8.00 price objective on the biotechnology company’s... More of this article »
Image about Apellis Pharmaceuticals (NASDAQ:APLS) Given Neutral Rating at Mizuho

Apellis Pharmaceuticals (NASDAQ:APLS) Given Neutral Rating at Mizuho

Mizuho reaffirmed their neutral rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a $60.00 price target on the stock. Other... More of this article »
Image about Westport Fuel Systems (NASDAQ:WPRT) Receives Outperform Rating from Oppenheimer

Westport Fuel Systems (NASDAQ:WPRT) Receives Outperform Rating from Oppenheimer

Oppenheimer reissued their outperform rating on shares of Westport Fuel Systems (NASDAQ:WPRT – Free Report) (TSE:WPRT) in a report published on Wednesday, Benzinga reports. The firm currently has a $19.00 price target on the... More of this article »
Image about Direct Digital (NASDAQ:DRCT) Given “Market Perform” Rating at Noble Financial

Direct Digital (NASDAQ:DRCT) Given “Market Perform” Rating at Noble Financial

Noble Financial reaffirmed their market perform rating on shares of Direct Digital (NASDAQ:DRCT – Free Report) in a research report report published on Wednesday morning, MarketBeat.com reports. Several other research firms... More of this article »
Image about BlackLine (NASDAQ:BL) Given New $66.00 Price Target at Citigroup

BlackLine (NASDAQ:BL) Given New $66.00 Price Target at Citigroup

BlackLine (NASDAQ:BL – Free Report) had its price objective upped by Citigroup from $57.00 to $66.00 in a research note published on Wednesday morning, Benzinga reports. Citigroup currently has a neutral rating on the technology... More of this article »
Image about Outlook Therapeutics (NASDAQ:OTLK) Upgraded by BTIG Research to “Buy”

Outlook Therapeutics (NASDAQ:OTLK) Upgraded by BTIG Research to “Buy”

BTIG Research upgraded shares of Outlook Therapeutics (NASDAQ:OTLK – Free Report) from a neutral rating to a buy rating in a research note published on Wednesday, MarketBeat Ratings reports. BTIG Research currently has $50.00... More of this article »
Image about Progress Software’s (PRGS) Outperform Rating Reaffirmed at Oppenheimer

Progress Software’s (PRGS) Outperform Rating Reaffirmed at Oppenheimer

Oppenheimer reaffirmed their outperform rating on shares of Progress Software (NASDAQ:PRGS – Free Report) in a research report report published on Wednesday morning, Benzinga reports. The firm currently has a $66.00 price objective... More of this article »
Image about Corvus Pharmaceuticals’ (CRVS) Neutral Rating Reaffirmed at Mizuho

Corvus Pharmaceuticals’ (CRVS) Neutral Rating Reaffirmed at Mizuho

Mizuho reaffirmed their neutral rating on shares of Corvus Pharmaceuticals (NASDAQ:CRVS – Free Report) in a research note released on Wednesday, Benzinga reports. They currently have a $3.50 price target on the stock. Separately,... More of this article »
Image about Adobe (NASDAQ:ADBE) Receives Outperform Rating from BMO Capital Markets

Adobe (NASDAQ:ADBE) Receives Outperform Rating from BMO Capital Markets

BMO Capital Markets reiterated their outperform rating on shares of Adobe (NASDAQ:ADBE – Free Report) in a research note released on Wednesday, Benzinga reports. BMO Capital Markets currently has a $610.00 price target on the... More of this article »
Image about Cognition Therapeutics (NASDAQ:CGTX) Given “Outperform” Rating at Oppenheimer

Cognition Therapeutics (NASDAQ:CGTX) Given “Outperform” Rating at Oppenheimer

Oppenheimer reaffirmed their outperform rating on shares of Cognition Therapeutics (NASDAQ:CGTX – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a $9.00 price objective... More of this article »